Personalis announces the launch of sherpa™ for high-accuracy neoantigen prediction and cancer diagnostic biomarker development

Menlo park, calif.--(business wire)---- $srpt #precisiononcology--personalis announces the launch of sherpa™ for high-accuracy neoantigen prediction and cancer diagnostic biomarker development

SRPT Ratings Summary

SRPT Quant Ranking